Dr. Lal PathLabs Limited (LALPATHLAB) Stock Forecast & Price Target

Compare

1 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

LALPATHLAB Analyst Ratings

Hold

0 Buy

1 Hold

0 Sell

Based on 1 analysts giving stock ratings to

Dr.

Lal PathLabs Limited

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

LALPATHLAB Stock 12 Month Forecast

Average Price Target

₹1,577.00

▲(7.06% Upside)

Based on 1 Wall Street analysts offering 12 month price targets for Dr. Lal PathLabs Limited in the last 3 months. The average price target is ₹1,577.00 with a high forecast of ₹1,577.00 and a low forecast of ₹1,577.00. The average price target represents a 7.06% change from the last price of ₹1,472.95.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"1143":"₹1,143","1628":"₹1,628","1264.25":"₹1,264.3","1385.5":"₹1,385.5","1506.75":"₹1,506.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":1577,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">₹1.58K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1577,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">₹1.58K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":1577,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">₹1.58K</span>\n  </div></div>","useHTML":true}}],"tickPositions":[1143,1264.25,1385.5,1506.75,1628],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"May<br/>2025","6":"Aug<br/>2025","9":"Nov<br/>2025","12":"Feb<br/>2026","25":"Feb<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1416.614,1428.9513846153845,1441.2887692307693,1453.6261538461538,1465.9635384615385,1478.300923076923,1490.6383076923078,1502.9756923076923,1515.313076923077,1527.6504615384615,1539.9878461538462,1552.3252307692308,1564.6626153846155,{"y":1577,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1416.614,1428.9513846153845,1441.2887692307693,1453.6261538461538,1465.9635384615385,1478.300923076923,1490.6383076923078,1502.9756923076923,1515.313076923077,1527.6504615384615,1539.9878461538462,1552.3252307692308,1564.6626153846155,{"y":1577,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1416.614,1428.9513846153845,1441.2887692307693,1453.6261538461538,1465.9635384615385,1478.300923076923,1490.6383076923078,1502.9756923076923,1515.313076923077,1527.6504615384615,1539.9878461538462,1552.3252307692308,1564.6626153846155,{"y":1577,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":1410.439,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1144.816,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1191.184,"date":1743465600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":1371.231,"date":1746057600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":1377.873,"date":1748736000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":1378.19,"date":1751328000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":1577.044,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1627.861,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1575.585,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1561.104,"date":1761955200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":1524.171,"date":1764547200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":1505.143,"date":1767225600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":1416.614,"date":1769904000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target₹1,577

Average Price Target₹1,577

Lowest Price Target₹1,577

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Unknown Analyst

Geojit Research

Not Ranked

Geojit Research

₹1,577

Hold

7.06%

Upside

Reiterated

02/17/26

Geojit Research Sticks to Their Hold Rating for Dr. Lal PathLabs Limited (LALPATHLAB)

Saion Mukherjee

Nomura

₹1,780→₹1,935

Buy

31.37%

Upside

Reiterated

08/04/25

Nomura Remains a Buy on Dr. Lal PathLabs Limited (LALPATHLAB)

Abdulkader Puranwala

ICICI Securities

₹1,450→₹1,500

Hold

1.84%

Upside

Reiterated

08/01/25

Dr. Lal PathLabs Limited (LALPATHLAB) Gets a Hold from ICICI Securities

Vivek Agrawal CFA

Citi

₹1,425→₹1,350

Sell

-8.35%

Downside

Reiterated

04/27/25

Dr Lal PathLabs Ltd (DLPL:IN) PT Lowered to INR2,700 at CitiCiti analyst Vivek Agrawal lowered the price target on Dr Lal PathLabs Ltd (DLPL:IN) to INR2,700.00 (from INR2,850.00) while maintaining a Sell rating.

Shyam Srinivasan

Goldman Sachs

₹1,337.5→₹1,325

Sell

-10.04%

Downside

Reiterated

04/26/25

Dr Lal PathLabs Ltd (DLPL:IN) PT Lowered to INR2,650 at Goldman SachsGoldman Sachs analyst Shyam Srinivasan lowered the price target on Dr Lal PathLabs Ltd (DLPL:IN) to INR2,650.00 (from INR2,675.00) while maintaining a Sell rating.

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Unknown Analyst

Geojit Research

Not Ranked

Geojit Research

₹1,577

Hold

7.06%

Upside

Reiterated

02/17/26

Geojit Research Sticks to Their Hold Rating for Dr. Lal PathLabs Limited (LALPATHLAB)

Saion Mukherjee

Nomura

₹1,780→₹1,935

Buy

31.37%

Upside

Reiterated

08/04/25

Nomura Remains a Buy on Dr. Lal PathLabs Limited (LALPATHLAB)

Abdulkader Puranwala

ICICI Securities

₹1,450→₹1,500

Hold

1.84%

Upside

Reiterated

08/01/25

Dr. Lal PathLabs Limited (LALPATHLAB) Gets a Hold from ICICI Securities

Vivek Agrawal CFA

Citi

₹1,425→₹1,350

Sell

-8.35%

Downside

Reiterated

04/27/25

Shyam Srinivasan

Goldman Sachs

₹1,337.5→₹1,325

Sell

-10.04%

Downside

Reiterated

04/26/25

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Dr. Lal PathLabs Limited

3 Months

xxx

Success Rate

2/2 ratings generated profit

Average Return

+1.80%

a xxx

rating ―

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +1.80% per trade.

1 Year

Google Health Care INTipRanks - Google

Success Rate

2/2 ratings generated profit

Average Return

+1.80%

a rating ―

Copying Google Health Care IN's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +1.80% per trade.

2 Years

xxx

Success Rate

2/2 ratings generated profit

Average Return

+1.80%

a xxx

rating ―

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +1.80% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

LALPATHLAB Analyst Recommendation Trends

Rating

Oct 25

Nov 25

Dec 25

Jan 26

Feb 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, LALPATHLAB has received 0 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. LALPATHLAB average Analyst price target in the past 3 months is 1,577.00.

Each month's total comprises the sum of three months' worth of ratings.

LALPATHLAB Financial Forecast

LALPATHLAB Earnings Forecast

Next quarter’s earnings estimate for LALPATHLAB is ₹7.40 with a range of ₹6.80 to ₹8.56. The previous quarter’s EPS was ₹6.70. LALPATHLAB beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year LALPATHLAB has Performed in-line its overall industry.

LALPATHLAB Sales Forecast

Next quarter’s sales forecast for LALPATHLAB is ₹6.81B with a range of ₹6.67B to ₹6.95B. The previous quarter’s sales results were ₹6.60B. LALPATHLAB beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year LALPATHLAB has Performed in-line its overall industry.

LALPATHLAB Stock Forecast FAQ

What is IN:LALPATHLAB’s average 12-month price target, according to analysts?

Based on analyst ratings, Dr. Lal PathLabs Limited’s 12-month average price target is 1,577.00.

What is IN:LALPATHLAB’s upside potential, based on the analysts’ average price target?

Dr. Lal PathLabs Limited has 7.06% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Dr. Lal PathLabs Limited a Buy, Sell or Hold?

Dr. Lal PathLabs Limited has a consensus rating of Hold, which is based on 0 buy ratings, 1 hold ratings and 0 sell ratings.

What is Dr. Lal PathLabs Limited’s share price target?

The average share price target for Dr. Lal PathLabs Limited is 1,577.00. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is ₹1,577.00 ,and the lowest forecast is ₹1,577.00. The average share price target represents 7.06% Increase from the current price of ₹1,472.95.

What do analysts say about Dr. Lal PathLabs Limited?

Dr. Lal PathLabs Limited’s analyst rating consensus is a Hold. This is based on the ratings of 1 Wall Streets Analysts.

How can I buy shares of Dr. Lal PathLabs Limited?

To buy shares of IN:LALPATHLAB, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Dr. Lal PathLabs Limited (LALPATHLAB) Stock Forecast & Price Target

LALPATHLAB Analyst Ratings

LALPATHLAB Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Dr. Lal PathLabs Limited

LALPATHLAB Analyst Recommendation Trends

LALPATHLAB Financial Forecast

LALPATHLAB Earnings Forecast

LALPATHLAB Sales Forecast

LALPATHLAB Stock Forecast FAQ

Detailed List of Analyst Forecasts